Literature DB >> 19819313

Characteristics and comparative severity of respiratory response to toxic doses of fentanyl, methadone, morphine, and buprenorphine in rats.

Lucie Chevillard1, Bruno Mégarbane, Patricia Risède, Frédéric J Baud.   

Abstract

Opioids are known to induce respiratory depression. We aimed to characterize in rats the effects of four opioids on arterial blood gases and plethysmography after intraperitoneal administration at 80% of their LD(50) in order to identify opioid molecule-specific patterns and classify response severity. Opioid-receptor (OR) antagonists, including intravenous 10 mg kg(-1)-naloxonazine at 5 min [mu-OR antagonist], subcutaneous 30 mg kg(-1)-naloxonazine at 24 h [mu1-OR antagonist], subcutaneous 3 mg kg(-1)-naltrindole at 45 min [delta-OR antagonist], and subcutaneous 5 mg kg(-1)-Nor-binaltorphimine at 6 h [kappa-OR antagonist] were pre-administered to test the role of each OR. Methadone, morphine, and fentanyl significantly decreased PaO(2) (P<0.001) and increased PaCO(2) (P<0.05), while buprenorphine only decreased PaO(2) (P<0.05). While all opioids significantly increased inspiratory time (T(I), P<0.001), methadone and fentanyl also increased expiratory time (T(E), P<0.05). Intravenous 10 mg kg(-1)-naloxonazine at 5 min completely reversed opioid-related effects on PaO(2) (P<0.05), PaCO(2) (P<0.001), T(I) (P<0.05), and T(E) (P<0.01) except in buprenorphine. Subcutaneous 30 mg kg(-1)-naloxonazine at 24 h completely reversed effects on PaCO(2) (P<0.01) and T(E) (P<0.001), partially reversed effects on T(I) (P<0.001), and did not reverse effects on PaO(2). Naltrindole reversed methadone-induced T(E) increases (P<0.01) but worsened fentanyl's effect on PaCO(2) (P<0.05) and T(I) (P<0.05). Nor-binaltorphimine reversed morphine- and buprenorphine-induced T(I) increases (P<0.001) but worsened methadone's effect on PaO(2) (P<0.05) and morphine (P<0.001) and buprenorphine's (P<0.01) effects on pH. In conclusion, opioid-related respiratory patterns are not uniform. Opioid-induced hypoxemia as well as increases in T(I) and T(E) are caused by mu-OR, while delta and kappa-OR roles appear limited, depending on the specific opioid. Regarding severity of opioid-induced respiratory effects at 80% of their LD(50), all drugs increased T(I). Methadone and fentanyl induced hypoxemia, hypercapnia, and T(E) increases, morphine caused both hypoxemia and hypercapnia while buprenorphine caused only hypoxemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19819313     DOI: 10.1016/j.toxlet.2009.09.017

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  9 in total

1.  Bifunctional Peptide-Based Opioid Agonist-Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic Pain.

Authors:  Karel Guillemyn; Joanna Starnowska; Camille Lagard; Jolanta Dyniewicz; Ewelina Rojewska; Joanna Mika; Nga N Chung; Valérie Utard; Piotr Kosson; Andrzej W Lipkowski; Lucie Chevillard; Pol Arranz-Gibert; Meritxell Teixidó; Bruno Megarbane; Dirk Tourwé; Frédéric Simonin; Barbara Przewlocka; Peter W Schiller; Steven Ballet
Journal:  J Med Chem       Date:  2016-04-14       Impact factor: 7.446

2.  Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo.

Authors:  Sylvain Auvity; Sébastien Goutal; Fabien Caillé; Dominique Vodovar; Alain Pruvost; Catriona Wimberley; Claire Leroy; Matteo Tonietto; Michel Bottlaender; Nicolas Tournier
Journal:  Neuropsychopharmacology       Date:  2021-02-18       Impact factor: 7.853

3.  Methocinnamox Reverses and Prevents Fentanyl-Induced Ventilatory Depression in Rats.

Authors:  Victor M Jimenez; Gabriel Castaneda; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2021-01-11       Impact factor: 4.030

4.  Subcutaneous Implants of a Cholesterol-Triglyceride-Buprenorphine Suspension in Rats.

Authors:  M Guarnieri; C Brayton; R Sarabia-Estrada; B Tyler; P McKnight; L DeTolla
Journal:  J Vet Med       Date:  2017-04-09

5.  Developing an animal model to detect drug-drug interactions impacting drug-induced respiratory depression.

Authors:  Lin Xu; Ashok Chockalingam; Sharron Stewart; Katherine Shea; Murali K Matta; Suresh Narayanasamy; Nageswara R Pilli; Donna A Volpe; James Weaver; Hao Zhu; Michael C Davis; Rodney Rouse
Journal:  Toxicol Rep       Date:  2020-01-25

6.  D-Cysteine Ethyl Ester Reverses the Deleterious Effects of Morphine on Breathing and Arterial Blood-Gas Chemistry in Freely-Moving Rats.

Authors:  Paulina M Getsy; Santhosh M Baby; Walter J May; Alex P Young; Benjamin Gaston; Matthew R Hodges; Hubert V Forster; James N Bates; Christopher G Wilson; Tristan H J Lewis; Yee-Hee Hsieh; Stephen J Lewis
Journal:  Front Pharmacol       Date:  2022-06-23       Impact factor: 5.988

7.  L-cysteine methyl ester overcomes the deleterious effects of morphine on ventilatory parameters and arterial blood-gas chemistry in unanesthetized rats.

Authors:  Paulina M Getsy; Santhosh M Baby; Walter J May; James N Bates; Christopher R Ellis; Michael G Feasel; Christopher G Wilson; Tristan H J Lewis; Benjamin Gaston; Yee-Hsee Hsieh; Stephen J Lewis
Journal:  Front Pharmacol       Date:  2022-09-28       Impact factor: 5.988

8.  Time-Dependent Changes in the Serum Levels of Neurobiochemical Factors After Acute Methadone Overdose in Adolescent Male Rat.

Authors:  Leila Ahmad-Molaei; Mahsa Pourhamzeh; Reza Ahadi; Fariba Khodagholi; Hossein Hassanian-Moghaddam; Abbas Haghparast
Journal:  Cell Mol Neurobiol       Date:  2020-07-25       Impact factor: 5.046

9.  Delay-Dependent Impairments in Memory and Motor Functions After Acute Methadone Overdose in Rats.

Authors:  Leila Ahmad-Molaei; Hossein Hassanian-Moghaddam; Fariba Farnaghi; Carlos Tomaz; Abbas Haghparast
Journal:  Front Pharmacol       Date:  2018-09-10       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.